• Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

  • 2024/02/06
  • 再生時間： 12 分
  • ポッドキャスト

Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents.

    Related Content:

    • Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents.

Related Content:

  • Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
続きを読む 一部表示

Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescentsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。